We continue the series topic, Digital Therapeutics known as medical treatments that can make medical claims, and receive regulatory authorization and reimbursement.

In this episode, MIDI Principal, Greg Montalbano will dive into the details of Digital Therapeutics covering:

This series will review the evolution of digital health from isolated remote monitoring technologies ten years ago to an emerging subset of evidence-based, clinically evaluated software products and services. MIDI Principal, Greg Montalbano discusses current and future medical digital healthcare application development that is now moving faster than ever creating an increasingly crowded digital healthcare market. He discusses how the digital therapeutic revolution has generated new healthcare business model opportunities as well as global regulatory, market, and operating model challenges for healthcare and life science companies.

In this special episode, MedDevice Supply Chain Paradigm Shift; Defining & Solving for Supply Chain Risk Utilizing MIDI’s De-Risk Method of DFSC, Chris and Pat will share unique and critical knowledge with the medical community.

Chris and Pat step us through the “trials and tribulations” MIDI’s development teams have endured over the last 2 years and reveal unique strategic methods that MIDI has deployed to mitigate our clients' risk in this uncertain world of supply. These approaches are not only critical to our clients' “financial viability” but of course critical to the “health of the general public” as related to being able to gain access to critical medical device technology.

Chris Montalbano, CEO of MIDI walks us through the components of DFX (Design for Excellence). Listen in as Chris "unpacks" each of the DFX components in detail referencing MIDI's methodical yet prudent development approach. Both the functional engineering constraints and the essential business constraints as related to production and costing are considered simultaneously in this development approach.

The subject of addressing supply chain issues is quite an important and relevant topic for medical device manufacturers to integrate into their development strategies given the material and component shortages in today's economic environment. The first episode in the new MIDI series, Value of Concurrent Engineering with Inclusion of DFX in MedDevice, Operationalized under ISO-13485, addresses how is it related to an advanced DFX strategy.

Chris Montalbano, CEO of MIDI, helps to define DFX. Additionally, Chris talks about how to operationalize DFX early in the development cycle under a Concurrent Engineering approach as well as what this approach entails and how it is different from alternative approaches.

In the last podcast episode of the series, MIDI Medical Product Developments CEO, Gregory Montalbano shares his personal insight as related to what an Accelerator or Incubator can and should be doing for its MedTech Startup entrepreneurial members.

Greg also outlines the “Five Accelerator Model Types” and reveals each accelerator type's own motivations for establishing programs, investing resources and capital as well as the different metrics MedTech Accelerators use for measuring a start-ups success.

In this episode, Gregory Montalbano speaks with Dr. Tom Luby who is the Director of Innovation at Texas Medical Center also known as TMC Innovation. In this role, Tom oversees all of the innovation efforts of TMC focused on research, education, and commercialization of novel healthcare solutions. Prior to Tom's role at TMC, he was the head of JLABS at TMC in Houston, Texas.

In this episode, a deep-dive will be taken into the inner-workings of the Houston TMC Innovation and JLABS ecosystem. Greg and Tom discuss the methods of mentoring and support offered to the entrepreneurial groups spanning medical, scientific, and biotechnology applications. Tom also outlines the various TMC & JLABS corporate, university, industry as well as venture partner networks that support their members. Greg and Tom’s discussion also includes what TMC Innovation looks for in a startup and how they can apply to TMC’s programs.